Express Scripts (ESRX) has several traits which may attract investors, including consistent earnings growth over the last few years. In addition, many qualitative factors make the company interesting to numerous investors. For example, Seeking Alpha contributor Insider Monkey recently wrote regarding the effect industry consolidation may have on the company’s margins. This is a great qualitative issue to consider, but one must first look at a quantitative analysis of the company.
In fact, Benjamin Graham, the father of value investing, taught that the most important aspect to consider is whether the company is trading at a discount relative to its intrinsic value. It is through a thorough fundamental analysis that the investor is able to determine a potential investment’s merits. Here’s an updated look at how the company fares in the ModernGraham valuation model.
This model is inspired by the teachings of Benjamin Graham and considers numerous metrics intended to help the investor reduce risk levels. The first part of the analysis is to determine whether the company is suitable for the very conservative Defensive Investor or the less conservative Enterprising Investor who is willing to spend a greater amount of time conducting further research.
In addition, Graham strongly suggested that investors avoid speculation in order to remove the subjective elements of emotion. This is best achieved by utilizing a systematic approach to analysis that will provide investors with a sense of how a specific company compares to another. By using theModernGraham method, one can review a company’s historical accomplishments and determine an intrinsic value that can be compared across industries.
To read the rest of this valuation, you must be logged in as a premium member. If you are not a premium member, please consider becoming one.
Defensive Investor – Must pass at least 6 of the following 7 tests: Score = 3/7
- Adequate Size of Enterprise – Market capitalization of at least $2 billion – PASS
- Sufficiently Strong Financial Condition – Current ratio greater than 2 – FAIL
- Earnings Stability – Positive earnings per share for at least 10 straight years – PASS
- Dividend Record – Has paid a dividend for at least 10 straight years – FAIL
- Earnings Growth – Earnings per share has increased by at least one-third over the last 10 years, using three-year averages at the beginning and end of the period – PASS
- Moderate PEmg (price over normalized earnings) ratio – PEmg is less than 20 – FAIL
- Moderate Price to Assets – PB ratio is less than 2.5 or PB x PEmg is less than 50 – FAIL
Enterprising Investor – Must pass at least 4 of the following 5 tests to be suitable for a Defensive Investor: Score = 2/5
- Sufficiently Strong Financial Condition, Part 1 – Current ratio greater than 1.5 – FAIL
- Sufficiently Strong Financial Condition, Part 2 – Debt-to-Net Current Assets ratio less than 1.1 – FAIL
- Earnings Stability – Positive earnings per share for at least 5 years – PASS
- Dividend Record – Currently pays a dividend – FAIL
- Earnings Growth – EPSmg greater than that 5 years ago – PASS
|MG Opinion||Fairly Valued|
|Value Based on 3% Growth||$48.58|
|Value Based on 0% Growth||$28.48|
|Market Implied Growth Rate||9.32%|
|Net Current Asset Value (NCAV)||-$30.09|
Balance Sheet – March 2015
Earnings Per Share
Earnings Per Share – ModernGraham
Express Scripts does not pay a dividend.
Express Scripts does not qualify for either the Enterprising Investor or the more conservative Defensive Investor. The Defensive Investor is concerned by the low current ratio, lack of dividends, and the high PEmg and PB ratios, while the Enterprising Investor is concerned with the level of debt relative to the current assets and the lack of dividends. Therefore, all value investors should only proceed with the next stage of the analysis, which is a determination of an estimate of intrinsic value, with a speculative attitude in mind.
From a valuation side of things, the company has grown its EPSmg (normalized earnings) from $2.01 in 2012 to an estimated $3.35 for 2016. This level of demonstrated growth supports the market’s implied estimate for earnings growth of 9.32% over the next 7-10 years.
The company’s recent earnings history shows an average annual growth in EPSmg of around 13.32%; however, the ModernGraham valuation model reduces such a rate to a more conservative figure, assuming some slowdown will occur. Even so, the model returns an estimate of intrinsic value falling within a margin of safety relative to the current price, indicating Express Scripts is fairly valued at the present time.
Disclaimer: Â The author did not hold aÂ position in any company mentioned in this articleÂ at the time of publication and had no intention of changing that position within the next 72 hours. Â Logo taken from Wikipedia for the sole purpose of identifying the company; this article is not affiliated with the company in any manner.